Abstract
Migraine is a neurovascular disorder that is characterized by repeated headaches, resulting in a reduction in the quality of life due to disabling pain. This clinical condition affects about 15% of the world's population, representing a serious public health problem. Botulinum toxin type A (BTx-A), has become widely used for the treatment of migraines. Objective: The objective of this rev…